4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-25-120152
Options or other derivatives
- President/CEO bought 42,918 shares at $1.17 ($25,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gilad Oren President/CEO | 2025-12-10 | Purchase · Pre-Funded Warrant | +21,459 | $1.17 | $25,000 | 21,459 | D |
| Gilad Oren President/CEO | 2025-12-10 | Purchase · Common Warrants | +21,459 | 21,459 | D | ||
Loading xslF345X05/tm2533219-1_4seq1.xml…